Pharmacologic treatment of sleep-disordered breathing.

Available literature on the use of pharmacologic agents for the treatment of sleep-disordered breathing was reviewed by evidenced-based methodology. Evidence tables were created and studies were graded according to study design and the number of subjects included. Scores for each group of studies evaluating each pharmacologic agent were established so that the quality of research for different drugs could be compared. The use of various ventilatory stimulants, psychotropic drugs, and antihypertensive agents were reviewed. The most objective data are available on theophylline and opioid antagonist/nicotine groups. Although more controlled studies would be helpful, relatively clear-cut indications for the use of ventilatory stimulants exist for hypercapnic obesity-hypoventilation patients (medroxyprogesterone), myxedema (thyroid replacement), central apnea (acetazolamide), and periodic breathing in congestive heart failure (theophylline). Few randomized, well-controlled trials have been published that evaluate pharmacologic agents in the treatment of classic OSA. To date, no one agent stands out as being useful for OSA. Future research will need to characterize subjects so that various subsets of patients can be tried on one or on a combination of various pharmacologic agents.

[1]  C. Haslett,et al.  Modulation of human endothelial thrombomodulin by neutrophils and their release products. , 1997, American journal of respiratory and critical care medicine.

[2]  S. Javaheri,et al.  Effect of theophylline on sleep-disordered breathing in heart failure. , 1996, The New England journal of medicine.

[3]  D. Carley,et al.  Hydralazine reduces elevated sleep apnea index in spontaneously hypertensive (SHR) rats to equivalence with normotensive Wistar-Kyoto rats. , 1996, Sleep.

[4]  J. Hedner,et al.  A double-blind, randomized trial of sabeluzole--a putative glutamate antagonist--in obstructive sleep apnea. , 1996, Sleep.

[5]  R. Mcevoy,et al.  The effects of the GABA agonist, baclofen, on sleep and breathing. , 1995, The European respiratory journal.

[6]  J. Verbraecken,et al.  Central apnea index decreases after prolonged treatment with acetazolamide. , 1995, American journal of respiratory and critical care medicine.

[7]  N. Collop.  Medroxyprogesterone acetate and ethanol-induced exacerbation of obstructive sleep apnea. , 1994, Chest.

[8]  M. Badr,et al.  Treatment of refractory sleep apnea with supplemental carbon dioxide. , 1994, American journal of respiratory and critical care medicine.

[9]  C. D. Harris,et al.  Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. , 1994, American journal of respiratory and critical care medicine.

[10]  P. Cistulli,et al.  Effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. , 1994, Thorax.

[11]  C. C. Lin,et al.  The relationship between sleep apnea syndrome and hypothyroidism. , 1992, Chest.

[12]  S. Woolf.  Practice guidelines, a new reality in medicine. II. Methods of developing guidelines. , 1992, Archives of internal medicine.

[13]  W. McNicholas,et al.  Theophylline in obstructive sleep apnea. A double-blind evaluation. , 1992, Chest.

[14]  F. Issa.  Effect of clonidine in obstructive sleep apnea. , 1992, The American review of respiratory disease.

[15]  D. Hudgel,et al.  Response of obstructive sleep apnea to fluoxetine and protriptyline. , 1991, Chest.

[16]  W. Mendelson,et al.  Buspirone administration to sleep apnea patients. , 1991, Journal of clinical psychopharmacology.

[17]  D. White,et al.  Chemosensitivity and the ventilatory response to airflow obstruction during sleep. , 1989, Journal of applied physiology.

[18]  T. Gislason,et al.  Increased CSF opioid activity in sleep apnea syndrome. Regression after successful treatment. , 1989, Chest.

[19]  W. Cook,et al.  Indices of severity of obstructive sleep apnea syndrome do not change during medroxyprogesterone acetate therapy. , 1989, Chest.

[20]  H. Kimura,et al.  Progesterone therapy for sleep apnea syndrome evaluated by occlusion pressure responses to exogenous loading. , 1989, The American review of respiratory disease.

[21]  C. Sullivan,et al.  Sleep apnea and hypothyroidism: mechanisms and management. , 1988, The American journal of medicine.

[22]  C. Shapiro,et al.  Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. , 1988, Sleep.

[23]  C. Guilleminault,et al.  Periodic leg movement, sleep fragmentation and central sleep apnoea in two cases: reduction with Clonazepam. , 1988, The European respiratory journal.

[24]  D. Hudgel,et al.  Alteration in obstructive apnea pattern induced by changes in oxygen- and carbon-dioxide-inspired concentrations. , 1988, The American review of respiratory disease.

[25]  L. Findley,et al.  Plasma adenosine and hypoxemia in patients with sleep apnea. , 1988, Journal of applied physiology.

[26]  H. Kimura,et al.  Effects of acetazolamide in patients with the sleep apnoea syndrome. , 1988, Thorax.

[27]  W. Mills,et al.  Respiratory stimulants and sleep periodic breathing at high altitude. Almitrine versus acetazolamide. , 1987, The American review of respiratory disease.

[28]  R. Mcevoy,et al.  The effects of aminophylline on sleep and sleep-disordered breathing in patients with obstructive sleep apnea syndrome. , 1987, The American review of respiratory disease.

[29]  B. Jabbari,et al.  Effects of medroxyprogesterone acetate in obstructive sleep apnea. , 1986, Chest.

[30]  P. Lavie,et al.  Preliminary clinical experience with imipramine HCl in the treatment of sleep apnea syndrome. , 1986, European neurology.

[31]  J. Sharp,et al.  Effect of metabolic acidosis upon sleep apnea. , 1985, Chest.

[32]  P. Suratt,et al.  Naloxone improves sleep apnea in obese humans. , 1985, International journal of obesity.

[33]  K. Strohl,et al.  Nicotine: a different approach to treatment of obstructive sleep apnea. , 1985, Chest.

[34]  C. Zwillich,et al.  Obstructive sleep apnea in hypothyroidism. , 1984, Annals of internal medicine.

[35]  P. L. Smith,et al.  The effects of protriptyline in sleep-disordered breathing. , 1983, The American review of respiratory disease.

[36]  M. Kryger,et al.  Protriptyline in obstructive sleep apnea: a double-blind trial. , 1982, The New England journal of medicine.

[37]  L. Findley,et al.  Central Sleep Apnea: Improvement With Acetazolamide Therapy , 1982 .

[38]  T. Roth,et al.  Protriptyline in the treatment of sleep apnoea. , 1982, Thorax.

[39]  W. Orr,et al.  Myxedema and obstructive sleep apnea. , 1981, The American journal of medicine.

[40]  K. Strohl,et al.  Progesterone administration and progressive sleep apneas. , 1981, JAMA.

[41]  A J Block,et al.  Menopause, medroxyprogesterone and breathing during sleep. , 1981, The American journal of medicine.

[42]  H. Boudoulas,et al.  Sleep apnea , 1979, Neurology.

[43]  J. Weil,et al.  Effects of progesterone on chemosensitivity in normal men. , 1978, The Journal of laboratory and clinical medicine.

[44]  J. Dempsey,et al.  Ventilatory response to medroxyprogesterone acetate in normal subjects: time course and mechanism. , 1978, Journal of applied physiology: respiratory, environmental and exercise physiology.

[45]  J. Winnacker,et al.  SEVERE DEPRESSION OF THE RESPIRATORY CENTER IN MYXEDEMA. , 1964, The American journal of medicine.